Improved risk stratification in younger IDH wild-type glioblastoma patients by combining a 4-miRNA signature with MGMT promoter methylation status

BACKGROUND: The potential benefit of risk stratification using a 4-miRNA signature in combination with MGMT promoter methylation in IDH1/2 wild-type glioblastoma patients was assessed. METHODS: Primary tumors from 102 patients with comparable treatment from the LMU Munich (n = 37), the University Ho...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neurooncol Adv
Asıl Yazarlar: Unger, Kristian, Fleischmann, Daniel F, Ruf, Viktoria, Felsberg, Jörg, Piehlmaier, Daniel, Samaga, Daniel, Hess, Julia, Suresh, Marian Preetham, Mittelbronn, Michel, Lauber, Kirsten, Budach, Wilfried, Sabel, Michael, Rödel, Claus, Reifenberger, Guido, Herms, Jochen, Tonn, Jörg-Christian, Zitzelsberger, Horst, Belka, Claus, Niyazi, Maximilian
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2020
Konular:
Basic and Translational Investigations
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7712804/
https://ncbi.nlm.nih.gov/pubmed/33305269
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdaa137
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller